Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gina Klee

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 28, 2020
Gina Klee, Laura von Dücker, Patrick Terheyden
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 25, 2020
Sustained complete remission of extranodal NK/T-cell lymphoma, nasal type, following pembrolizumab and radiation therapyGina Klee, Laura von Dücker, Patrick Terheyden
Clinical Hemorheology and Microcirculation|January 14, 2020
The slow releasing hydrogen sulfide donor GYY4137 reduces neointima formation upon FeCl3 injury of the carotid artery in miceEberhard Grambow, Gina Klee, Ernst Klar, et al.
Clinical Hemorheology and Microcirculation|September 14, 2020
Hydrogen sulfide reduces the activity of human endothelial cellsEberhard Grambow, Gina Klee, Wentao Xie, et al.
International Journal of Molecular Sciences|September 23, 2022
Disease Recurrence during Adjuvant Immune Checkpoint Inhibitor Treatment in Metastatic Melanoma: Clinical, Laboratory, and Radiological Characteristics in Patients from a Single Tertiary Referral CenterJonas K Kurzhals, Gina Klee, Victoria Hagelstein, et al.
Melanoma Research|July 20, 2022
Dacarbazine in the management of metastatic melanoma in the era of immune checkpoint therapy: a valid option or obsolete?Gina Klee, Victoria Hagelstein, J K Kurzhals, et al.
Melanoma Research|July 20, 2021
Low-dose ipilimumab combined with anti-PD-1 immunotherapy in patients with metastatic melanoma following anti-PD-1 treatment failureGina Klee, Jonas Kurzhals, Victoria Hagelstein, et al.
Plos One|August 18, 2021
The impact of the Covid-19 pandemic on quality of life in skin cancer patientsJonas K Kurzhals, Gina Klee, Hauke Busch, et al.
Rheumatology Advances in Practice|October 8, 2021
The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritisGina Klee, Tobias Kisch, Christiane Kümpers, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 28, 2020
Gina Klee, Laura von Dücker, Patrick Terheyden
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 25, 2020
Sustained complete remission of extranodal NK/T-cell lymphoma, nasal type, following pembrolizumab and radiation therapyGina Klee, Laura von Dücker, Patrick Terheyden
Clinical Hemorheology and Microcirculation|January 14, 2020
The slow releasing hydrogen sulfide donor GYY4137 reduces neointima formation upon FeCl3 injury of the carotid artery in miceEberhard Grambow, Gina Klee, Ernst Klar, et al.
Clinical Hemorheology and Microcirculation|September 14, 2020
Hydrogen sulfide reduces the activity of human endothelial cellsEberhard Grambow, Gina Klee, Wentao Xie, et al.
International Journal of Molecular Sciences|September 23, 2022
Disease Recurrence during Adjuvant Immune Checkpoint Inhibitor Treatment in Metastatic Melanoma: Clinical, Laboratory, and Radiological Characteristics in Patients from a Single Tertiary Referral CenterJonas K Kurzhals, Gina Klee, Victoria Hagelstein, et al.
Melanoma Research|July 20, 2022
Dacarbazine in the management of metastatic melanoma in the era of immune checkpoint therapy: a valid option or obsolete?Gina Klee, Victoria Hagelstein, J K Kurzhals, et al.
Melanoma Research|July 20, 2021
Low-dose ipilimumab combined with anti-PD-1 immunotherapy in patients with metastatic melanoma following anti-PD-1 treatment failureGina Klee, Jonas Kurzhals, Victoria Hagelstein, et al.
Plos One|August 18, 2021
The impact of the Covid-19 pandemic on quality of life in skin cancer patientsJonas K Kurzhals, Gina Klee, Hauke Busch, et al.
Rheumatology Advances in Practice|October 8, 2021
The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritisGina Klee, Tobias Kisch, Christiane Kümpers, et al.
Pageof 1